SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-19-013662
Filing Date
2019-06-19
Accepted
2019-06-19 12:56:38
Documents
2
Period of Report
2019-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 2302
2 EXHIBIT 24.1 - POWER OF ATTORNEY poa_burstein.htm EX-24.1 4951
  Complete submission text file 0001567619-19-013662.txt   8691
Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Issuer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LOXO ONCOLOGY, INC. ONE LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901
Business Address
Burstein Jennifer (Reporting) CIK: 0001640069 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38938 | Film No.: 19905715